about
Tea, flavonoids, and cardiovascular health: endothelial protectionCocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trialBlack tea lowers blood pressure and wave reflections in fasted and postprandial conditions in hypertensive patients: a randomised study.Chronic hyperuricemia, uric acid deposit and cardiovascular riskC-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.Cardiovascular risk and cardiometabolic protection: role of glitazones.Peripheral vascular dysfunction in migraine: a reviewBlack Tea Increases Circulating Endothelial Progenitor Cells and Improves Flow Mediated Dilatation Counteracting Deleterious Effects from a Fat Load in Hypertensive Patients: A Randomized Controlled Study.Blood pressure and cardiovascular risk: what about cocoa and chocolate?Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis.Flavonoids: antioxidants against atherosclerosis.Protective effects of dark chocolate on endothelial function and diabetes.Hyperuricemia and cardiovascular risk.Therapeutic approaches to chronic hyperuricemia and gout.New Insight into Urate-Related Mechanism of Cardiovascular Damage.Cocoa, blood pressure, and cardiovascular health.Cocoa, glucose tolerance, and insulin signaling: cardiometabolic protection.Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature.Brain Protection and Cognitive Function: Cocoa Flavonoids as Nutraceuticals.Lipid profile changes after pomegranate consumption: A systematic review and meta-analysis of randomized controlled trials.Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway.Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.Antioxidants and beneficial microvascular effects: is this the remedy?Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols.Cocoa beans, endothelial function and aging: an unexpected friendship?Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons.Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia.Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals.Electrophysiological effects of short-term antihypertensive therapy.Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.Tea, flavonoids, and nitric oxide-mediated vascular reactivity.Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study.Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decreaseAortic stiffness, blood pressure and renal dysfunctionEnhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnantThe history of primary hyperaldosteronism with simultaneous hypercortisolismSoluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-upBlack tea consumption dose-dependently improves flow-mediated dilation in healthy males
P50
Q26824447-D66C2D1A-CEDD-40DF-9CC7-705F245E9689Q35120244-E59FFDD2-3ABD-46E1-9F73-588C4EA381FFQ35131350-C68CB108-C9F9-4770-87A7-BF956D157B82Q36712438-667E7D5A-BA38-43EA-9E93-2AEA245549D7Q36855606-27D6441C-A36D-443D-A529-1404A7D462DAQ37335217-91F29D53-5367-432D-BEF2-E2898FE25B88Q37362193-134DA1A4-CA8F-4121-A2FB-2FDFAEB1D12DQ37463348-78D9CC60-738C-443A-A880-0A5DECACC122Q37759916-D2D41C03-5091-426B-AC5F-DEAC97590DA7Q37828575-95F057E2-ECB7-4441-A064-FA393D104830Q37976698-45896A70-FF81-41D7-A902-6D97321A6CB2Q38150145-227421FA-3E4D-4F96-88EC-CBA72A35C916Q38189754-F5C19355-63C8-4925-BA4C-2FEF8E4EC8AEQ38201666-42660B27-8F94-4737-811A-27A3BBA79E4EQ38205546-FA4DFFB6-538C-4739-9E01-553D56A32D88Q38540691-87D4EAAF-298B-48CD-AB34-EF42ECA7A0FAQ38540743-1893CB40-9611-4C22-BD40-6541DCD903CFQ38627962-8431EB8C-3B30-46B9-A814-0AA3DE9FC79EQ38631544-EA6E8E31-C4F4-495C-84D2-19C7CEFB5CA2Q38726854-45A0EFA0-53F1-482C-9EDB-E8432F9EAC50Q39905504-455B4DAE-E4CD-4967-9287-1A9FFA7C819BQ42282890-EE6E0A88-7267-4672-986D-E07AE7824591Q43084904-791F38E3-4593-4AC4-96B5-6DA6AA7BB212Q44243592-E628BFED-29F9-40F2-BDAC-0F0218A6E4B4Q44373264-F682D84B-22BA-4645-B7ED-61CF6357C57BQ44769520-4EB38B46-DFA7-4ADD-A5C2-097E9F1CC0DDQ44920445-F45876BC-A7F8-4256-B698-7BBECED7FCD6Q45762818-D8F4DFA3-A82F-4D61-9CD3-5494729A5E71Q46000132-FCC8FE6A-248C-41F6-BB37-5E44787708EAQ46238887-EBBE4C72-E9B5-4D65-82CB-524ED468FA22Q47926145-C5F86686-C9B9-498F-822E-AFB9AF86FA73Q50627144-73430553-98BC-4080-B1F5-F8AFD619ED47Q50746303-8F19CD34-16FE-4A1B-8D22-BDD14BD5C61DQ55050444-F91CDE9C-F3D8-4617-B7D8-85748D89A8A9Q79470571-51A35ACF-0AE2-4C7A-B468-44D42BF5DCEBQ82085340-109082C9-B44E-4CAF-9504-3DE12449A81EQ82891046-B60D806A-ED24-47B6-AED3-4C3C01661222Q83212559-2F741445-6E01-47B9-928F-4C2ADBE1CADFQ83389459-9C7C6947-E9A6-4CA7-B82A-6B8F806915D2Q84043308-9B2039B6-C5FC-4954-B1AD-2A85E0BB0877
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Davide Grassi
@ast
Davide Grassi
@en
Davide Grassi
@es
Davide Grassi
@sl
type
label
Davide Grassi
@ast
Davide Grassi
@en
Davide Grassi
@es
Davide Grassi
@sl
prefLabel
Davide Grassi
@ast
Davide Grassi
@en
Davide Grassi
@es
Davide Grassi
@sl
P214
P950
P1053
O-6519-2015
P106
P1153
35409231500
P21
P214
P31
P3829
P396
IT\ICCU\LZ1V\127276
P496
0000-0003-1005-4689
P569
1976-01-01T00:00:00Z
P734
P735
P7859
viaf-307414801